Werner Englberger - Concepedia

Author

Werner Englberger

Grünenthal Group (Germany)

Also Known As

Englberger, W., W Englberger, W. Englberger, WERNER ENGLBERGER, Werner Englberger

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Grünenthal Group (Germany)University of Münster Johannes Gutenberg University Mainz Pharmac

About

Werner Englberger is an author at Grünenthal Group (Germany) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	934
2	Health Sciences	4	4	176
3	Natural Sciences	4	4	128
4	Anesthesia	2	2	69
5	Social Sciences	1	1	182

Werner Englberger

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
(–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties Thomas Tzschentke, Thomas Christoph, Babette Kögel, Journal of Pharmacology and Experimental Therapeutics	2007	389
Influence of tramadol on neurotransmitter systems of the rat brain. MC Frink, Hennies Hh, Werner Englberger, PubMed NeurotransmitterPharmacotherapyExperimental PharmacologySocial SciencesRat Brain	1996	182
Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist Klaus Linz, Thomas Christoph, Thomas Tzschentke, Journal of Pharmacology and Experimental Therapeutics	2014	162
Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activity Werner Englberger, U. Hadding, E. Etschenberg, International Journal of Immunopharmacology InflammationComplement C3-convertaseAnti-inflammatoryMedicineRosmarinic Acid	1988	130
Agonistic Effect of Buprenorphine in a Nociceptin/OFQ Receptor-Triggered Reporter Gene Assay Stephan Wnendt, Thomas M. Krüger, Elke Janocha, Molecular Pharmacology	1999	94
Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol Stefan Schunk, Klaus Linz, Claudia Hinze, ACS Medicinal Chemistry Letters	2014	90
In vitro and in vivo characterization of tapentadol metabolites Rolf Terlinden, Babette-Y. Kögel, Werner Englberger, Methods and Findings in Experimental and Clinical Pharmacology Pharmaceutical SciencePain MedicineSecondary MetabolitePharmacotherapyExperimental Pharmacology	2010	79
Investigation of TRPV1 loss-of-function phenotypes in transgenic shRNA expressing and knockout mice Thomas Christoph, Gregor Bahrenberg, Jean De Vry, Molecular and Cellular Neuroscience Transcriptional RegulationTrpv1 Loss-of-function PhenotypesKnockout MiceTransgenic Shrna ExpressingSmall Rna	2008	77
Platelet Activating Factor (PAF) induces the oxidative burst in macrophages Hans‐Peter Hartung, Michael J. Parnham, Johannes Winkelmann, International Journal of Immunopharmacology InflammationThrombosisThrombopoiesisCytokineBlood Platelet	1983	74
The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism Thomas Christoph, Klaus Schiene, Werner Englberger, Neuropharmacology Pain SyndromePain MedicineMedicineVivo Nmda AntagonismNeuropathic Pain	2006	50

Page 1